CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in alaska native tobacco users

Addiction

Volumn 108, Issue 10, 2013, Pages 1818-1828

  Zhu, Andy Z X ^a   Renner, Caroline C ^b   Hatsukami, Dorothy K ^c   Benowitz, Neal L ^d   Tyndale, Rachel F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ALASKA NATIVE MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alaska Native people; CHRNA5 A3 B4; Obesity; Smoking

Indexed keywords

CHRNA5 PROTEIN, HUMAN; COTININE; COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; NERVE PROTEIN; NICOTINE; NICOTINIC RECEPTOR; UNSPECIFIC MONOOXYGENASE; CHRNB4 PROTEIN, HUMAN; CYP2A6 PROTEIN, HUMAN; CYTOCHROME P450 2A6; NICOTINIC RECEPTOR SUBUNIT ALPHA3;

ADULT; ALASKA NATIVE PEOPLE; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; CHEMISTRY; CHRNA5-A3-B4; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKELESS TOBACCO; SMOKING; TOBACCO; UNITED STATES; URINE; EPIDEMIOLOGY;

ALASKA NATIVE PEOPLE; CHRNA5-A3-B4; OBESITY; SMOKING;

ADULT; ALASKA; ARYL HYDROCARBON HYDROXYLASES; BODY MASS INDEX; BODY WEIGHT; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NICOTINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SMOKING; TOBACCO; TOBACCO, SMOKELESS; CYTOCHROME P-450 CYP2A6;

EID: 84884210585     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12250     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence-38 States and the District of Columbia, 1998-2006. Morb Mortal Wkly Rep 2010; 59: 1434-1438.
2. US Department of Health and Human Services. African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and Prevention; 1998.
3. Renner C. C., Lanier A. P., Lindgren B., Jensen J., Patten C. A., Parascandola M. etal. Tobacco use among Southwestern Alaska Native people. Nicotine Tob Res 2013; 15: 401-406.
4. Behavioral Risk Factor Surveillance System. Alaska Behavioral Risk Factor Survey 2008 Annual Report, Health RIsks in Alaska Among Adults 2008. Atlanta, GA: Centers for Disease Control and Prevention.
5. Thorgeirsson T. E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K. P. etal. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642.
6. Freathy R. M., Kazeem G. R., Morris R. W., Johnson P. C., Paternoster L., Ebrahim S. etal. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol 2011; 40: 1617-1628.
7. Thorgeirsson T. E., Gudbjartsson D. F., Surakka I., Vink J. M., Amin N., Geller F. etal. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010; 42: 448-453.
8. Amos C. I., Wu X., Broderick P., Gorlov I. P., Gu J., Eisen T. etal. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622.
9. Hung R. J., McKay J. D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D. etal. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633-637.
10. Saccone N. L., Wang J. C., Breslau N., Johnson E. O., Hatsukami D., Saccone S. F. etal. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 2009; 69: 6848-6856.
11. Keskitalo K., Broms U., Heliovaara M., Ripatti S., Surakka I., Perola M. etal. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 2009; 18: 4007-4012.
12. Munafo M. R., Timofeeva M. N., Morris R. W., Prieto-Merino D., Sattar N., Brennan P. etal. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst 2012; 104: 740-748.
13. Wassenaar C. A., Dong Q., Wei Q., Amos C. I., Spitz M. R., Tyndale R. F. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst 2011; 103: 1342-1346.
14. Le Marchand L., Derby K. S., Murphy S. E., Hecht S. S., Hatsukami D., Carmella S. G. etal. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res 2008; 68: 9137-9140.
15. Chen L. S., Saccone N. L., Culverhouse R. C., Bracci P. M., Chen C. H., Dueker N. etal. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry-a meta-analysis of chromosome 15q25. Genet Epidemiol 2012; 36: 340-351.
16. Saccone N. L., Schwantes-An T. H., Wang J. C., Grucza R. A., Breslau N., Hatsukami D. etal. Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav 2010; 9: 741-750.
17. Seeley R. J., Sandoval D. A. Neuroscience: weight loss through smoking. Nature 2011; 475: 176-177.
18. Mineur Y. S., Abizaid A., Rao Y., Salas R., Dileone R. J., Gundisch D. etal. Nicotine decreases food intake through activation of POMC neurons. Science 2011; 332: 1330-1332.
19. Audrain-McGovern J., Benowitz N. L. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther 2011; 90: 164-168.
20. Benowitz N. L., Renner C., Lanier A., Tyndale R. F., Hatsukami D. K., Lindgren B. R. etal. Exposure to nicotine and carcinogens among South Western Alaskan Native cigarette smokers and smokeless tobacco user. Cancer Epidemiol Biomarkers Prev 2012; 21: 934-942.
21. Binnington J. M., Zhu A. Z., Renner C. C., Lanier A. P., Hatsukami D. K., Benowitz N. L. etal. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. Pharmacogenet Genomics 2012; 22: 429-440.
22. Zhu A. Z., Binnington M. J., Renner C. C., Lanier A. P., Hatsukami D. K., Stepanov I. etal. Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco specific nitrosamine exposure and lower tobacco specific nitrosamine bioactivation. Carcinogenesis 2013; 34: 93-101.
23. Benowitz N. L., Jacob P. 3rd, Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994; 268: 296-303.
24. Hecht S. S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer, nature reviews. Cancer 2003; 3: 733-744.
25. Church T. R., Anderson K. E., Caporaso N. E., Geisser M. S., Le C. T., Zhang Y. etal. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev 2009; 18: 260-266.
26. Sthelen G., Goniewicz M. L., Dempsey D., Wilson M., Jacob P. III, Benowitz N. L. Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol 2012; 25: 952-964.
27. Dempsey D., Tutka P., Jacob P. 3rd, Allen F., Schoedel K., Tyndale R. F. etal. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004; 76: 64-72.
28. Bernert J. T., Alexander J. R., Sosnoff C. S., McGuffey J. E. Time course of nicotine and cotinine incorporation into samples of nonsmokers' beard hair following a single dose of nicotine polacrilex. J Anal Toxicol 2011; 35: 1-7.
29. Jacob P. 3rd, Wilson M., Benowitz N. L. Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem 2007; 79: 587-598.
30. Jacob P. 3rd, Havel C., Lee D. H., Yu L., Eisner M. D., Benowitz N. L. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem 2008; 80: 8115-8121.
31. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M. A., Bender D. etal. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
32. Barrett J. C., Fry B., Maller J., Daly M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
33. Bierut L. J., Stitzel J. A., Wang J. C., Hinrichs A. L., Grucza R. A., Xuei X. etal. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165: 1163-1171.
34. Fowler C. D., Lu Q., Johnson P. M., Marks M. J., Kenny P. J. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471: 597-601.
35. Zhu A. Z., Renner C., Hatsukami D. K., Swan G., Lerman C. E., Benowitz N. L. etal. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race and sex. Cancer Epidemiol Biomarkers Prev 2013; 22: 708-718.
36. Brennan P., Hainaut P., Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011; 12: 399-408.